Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Aventis Pharma Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, UK or trading as: Sanofi-aventis or Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
Cordarone X 150mg/3ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. |
Each 3ml ampoule contains 150mg amiodarone hydrochloride.
For excipients, see 6.1.
| Active Ingredient |
|---|
|
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. |
| List of Excipients |
|---|
|
Benzyl alcohol |
Cordarone X 150mg/3ml Solution for Injection is supplied in boxes containing 6 or 10 glass ampoules.
Not all pack sizes may be marketed.
Aventis Pharma Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
or trading as:
Sanofi-aventis or Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
PL 04425/0643
Date of first authorisation: 31 July 2010
| Drug | Countries | |
|---|---|---|
| CORDARONE | Australia, Germany, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.